ApiJect Systems focuses on revolutionizing drug delivery through its innovative Blow-Fill-Seal (BFS) technology. This platform enables the creation of prefilled injectors that are not only safe and high-performing but also affordable and accessible. By utilizing a single-dose BFS container combined with a proprietary pen needle hub, ApiJect aims to simplify the injection process, allowing for administration by non-medical professionals or patients themselves. The use of medical-grade plastic resin and stainless steel in their manufacturing process ensures a reliable supply chain while significantly reducing the carbon footprint compared to traditional glass vials and syringes.

The company emphasizes scalability and resilience in its manufacturing approach, which can quickly adapt to fluctuations in demand. ApiJect's commitment to global health is evident in its efforts to develop low-cost injection devices for low- and middle-income countries, thereby improving access to essential medications. Through its technology development center and partnerships, ApiJect is dedicated to enhancing the efficiency and effectiveness of drug delivery systems, ultimately aiming to make prefilled injections available to a broader population in various environments.

United States

ApiJect Systems, Corp. a medical technology company whose device development platform will make the safety and performance advantages of single-use prefilled syringes affordable.

The ApiJect Platform enables pharmaceutical and biotech companies to design scalable prefilled injectors and efficiently fill-finish them with their injectable drug products. This can be done either on one of their own ApiJect-licensed Blow-Fill-Seal packaging lines or at one of our world-class manufacturing partners.

ApiJect Systems

Company Details